Provider
QP31-20 Commercial Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Oxbryta™
Program effective Date: Mar 25, 2020
Documents & Forms Results
Displaying 2411 - 2420 of 3563 results
Provider
QP27-20 Coronavirus (COVID-19) Information for Providers
Program effective Date: Mar 11, 2020
Provider
2020 March Provider Press
Program effective Date: Feb 24, 2020
Provider
QP8-20 Medical Drug Update for New to Market Golodirsen (Vyondys 53)
Program effective Date: Jan 08, 2020
Provider
QP25-20 Pharmacy Benefit Exclusion for Injectafer®, Feraheme®, Venofer®, INFeD®, Ferrlecit®, and generic Ferrlecit®
Program effective Date: Mar 11, 2020
Provider
QP26-20 CMS Decision Memo on Acupuncture for Chronic Low Back Pain
Program effective Date: Mar 11, 2020
Provider
QP24-20 Pharmacy Benefit Update – Addition of Drugs to Existing Prior Authorization (PA) with Quantity Limit (QL) Programs
Program effective Date: Mar 11, 2020
Provider
QP8R1-20 Update: Medical Drug Update for Golodirsen (Vyondys 53)
Program effective Date: Mar 11, 2020
Provider
P20-20 Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Program effective Date: Mar 02, 2020
Provider
P19-20 New Medical, Medical Drug and Behavioral Health Policy Management Updates - Effective May 4, 2020
Program effective Date: Mar 02, 2020